Form 4: Inspire Medical Director Sells Shares Under 10b5-1 Plan

Shawn McCormick, a Director at Inspire Medical Systems, Inc., sold 2,000 shares of common stock for $127.48 per share under a pre-arranged trading plan.

Summary

• Shawn McCormick, a Director of Inspire Medical Systems, Inc. (INSP), reported the sale of 2,000 shares of common stock.
• The transaction occurred on November 28, 2025, at a price of $127.48 per share.
• The sale was executed pursuant to a Rule 10b5-1 trading plan established on August 29, 2025.
• Following the transaction, McCormick directly owns 26,046 shares of common stock and indirectly owns 3,000 shares through a trust.

Sentiment

Score: 4

Explanation: The sale of shares by a director is generally a slight negative, but the execution under a pre-arranged 10b5-1 plan mitigates concerns about discretionary selling based on new information, leading to a neutral-to-slightly negative sentiment.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, indicating it was pre-scheduled and not a discretionary sale based on new, non-public information.

Negatives

• A director of the company sold 2,000 shares of common stock, which can sometimes be perceived as a lack of confidence by investors.

Stakeholder Impact

• Shareholders may view the director's sale with caution, although the 10b5-1 plan suggests it was not based on new, adverse information.

Key Dates

Keywords

Inspire Medical Systems, INSP, Insider Trading, Form 4, Stock Sale, Director Transaction, 10b5-1 Plan